article thumbnail

Childhood vaccination coverage was falling across the globe even before Covid

STAT

Childhood vaccination coverage has made leaps since 1980. That is according to a study published in The Lancet Tuesday, which found stagnation and wide variation in childhood vaccination rates since 2010. But progress has significantly slowed in the last two decades. Read the rest…

Vaccines 356
article thumbnail

Cassidy calls to delay meeting of CDC’s vaccine panel in challenge to RFK Jr.

STAT

WASHINGTON — A key Senate health leader is calling for this week’s meeting of the panel of vaccine advisers handpicked by Health and Human Services Secretary Robert F. to be delayed, citing their lack of experience and potential bias against some vaccines. Kennedy Jr. Bill Cassidy (R-La.)   Read the rest…

Vaccines 363
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: Insurance coverage of vaccines at risk in RFK Jr.’s reshuffling of CDC’s vaccine advisers

STAT

to remove and replace all members of the government’s independent vaccine advisory committee doesn’t just change how the nation will approach vaccine policy. Kennedy Jr. It could also take money out of Americans’ wallets. Continue to STAT+ to read the full story…

Vaccines 337
article thumbnail

Cassidy says RFK Jr. briefed him on HHS job cuts, but reported study on vaccines, autism didn’t come up

STAT

as the nation’s health secretary last month on the condition that Kennedy, a longtime vaccine critic, keep him apprised of agency actions, especially those related to vaccines.  Bill Cassidy, the chairman of the Senate health committee, voted to confirm Robert F. Kennedy Jr.    Read the rest…

Vaccines 348
article thumbnail

As its cancer vaccine moves through the clinic, Transgene sets sights on manufacturing

PharmaVoice

Today, we’re speaking to Simone Steiner, Transgene’s new chief technology officer, about how the company is transitioning from early- to late-stage testing and advancing its manufacturing capabilities Oncology vaccines are gaining traction in the clinic as potential game changing treatments for cancer.

Vaccines 232
article thumbnail

STAT+: Vaccine developer raises $45M for influenza drug trial

STAT

Today, we talk about the readout of Compass Pathways’ psilocybin trial for major depressive disorder, see more vaccine concern and turnover at the FDA, and report from the American Diabetes Association. 

Vaccines 236
article thumbnail

Osivax publishes phase 2a results supporting dual flu vaccine approach

Pharma Times

The results, now published in Vaccines , show that the combination was well-tolerated with no serious adverse events, and generated strong immune responses. The results, now published in Vaccines , show that the combination was well-tolerated with no serious adverse events, and generated strong immune responses.